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We describe the epidemiologic and clinical character-
istics of 111 children attending clinics and hospitals in
Aracaju, northeast Brazil, with acute respiratory infections
attributable to human metapneumovirus (HMPV), respira-
tory syncytial virus (RSV), or both in May and June 2002.
Fifty-three (48%) children were infected with RSV alone, 19
(17%) with HMPV alone, and 8 (7%) had RSV/HMPV co-
infections. 
H
uman metapneumovirus (HMPV) was first identified
in the Netherlands in 2001 (1) and was implicated as
a potential etiologic agent for respiratory infections. Since
then, the virus has been reported from other European
countries (2–6), Asia (7–9), and North America (10–13),
findings that suggest it has a worldwide distribution.
However, HMPV has not been reported from South
America. We describe the epidemiologic and clinical char-
acteristics of 111 children attending clinics and hospitals in
Aracaju, northeast Brazil, with acute respiratory infections
attributable to HMPV, respiratory syncytial virus (RSV),
or both.
The Study
Children <3 years of age attending two health centers,
one public reference hospital (Joao Alves), and a private
hospital in Aracaju were invited to participate in our study
during April and May 2002. These months correspond to
the beginning of the rainy season, when most cases of
bronchiolitis occur. The health centers provide 24-hour
medical services for acute illnesses; patients with severe
health problems are referred to the public hospital. The
small private hospital caters to self-referred and trans-
ferred patients (mostly from the public hospital). Children
with diagnoses of acute lower respiratory infections
(ALRI) were recruited consecutively after informed
parental consent. The diagnosis of ALRI was based on the
presence of cough, tachypnea, chest indrawing, or wheeze
of <7 days’ duration and followed the World Health
Organization’s standard protocol for research on ALRI
(14). 
Nasopharyngeal secretions were collected by using
sterile mucous traps (Maesk Medical A/S, Bettina Bay,
Denmark). Immediately after collection, aspirates were
mixed with phosphate-buffered saline, transferred into 2-
mL cryotubes, and kept frozen at –80°C until analyzed.
Hypoxia levels were measured by pulse oximetry before
the use of oxygen, and children were treated according to
local guidelines for the management of ALRI.
Detection of the HMPV genome was performed by
reverse transcription–polymerase chain reaction amplifica-
tion (RT-PCR) of the matrix (M), fusion (F) and nucleo-
capsid (N) protein genes, as described previously (5).
Selected PCR products were cloned into a TAcloning vec-
tor (pGEM-T, Promega, UK), and the sequence was deter-
mined to confirm the identity of the virus detected by the
PCR reaction. Samples were defined as HMPV positive if
at least two of the RT-PCR test results were positive,
although in practice all positive samples had at least two
positive PCRs. Detection of RSV by RT-PCR was as
described by Fletcher et al. (15). 
A total of 111 children (57 from the health centers, 25
from Joao Alvez Hospital, and 29 from the private hospi-
tal) were recruited. Their ages ranged from 1 to 30 months
(median 7 months). Fifty-three (48%) children were infec-
ted with RSV alone, 19 (17%) with HMPV alone, and 8
(7%) with both (co-infections). Forty-six (88%) of the
RSV cases were of group A and 6 (12%) group B. 
The incidence of ALRI increased during the 10 weeks
of the study from no cases in the first 2 weeks, 4 cases in
the next 2 weeks, and up to 25 cases in week 9 (Figure 1).
RSV and HMPV infections appeared to coincide in time
during the period of the study.
The characteristics of the children are described in the
Table. The incidence of HMPV and RSV varied according
to the enrollment site. Eighteen (32%) of the 57 patients
attending the health centers had HMPV compared to 1
(4%) of the 25 infants attending the reference hospital (p =
0.01). In contrast, RSV was significantly (p = 0.01) more
frequently detected in patients attending the referral hospi-
tal (17 [68%] of 25) than the health centers (23 [40%] of
57). The age distribution of the infected infants is shown in
Figure 2. The greatest number of cases of RSV was
observed in children <12 months of age. HMPV infection
appeared to be more frequent in children 6–24 months of
age, although this finding was not statistically significant.
All children had coughing; 61 (55%) were wheezing,
which was audible without auscultation; and 34 (31%) had
chest indrawing. The mean respiratory rate on consultation
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University of Sergipe, Aracaju, Brazil  was higher in patients with RSV than in patients with
HMPV infection (p = 0.03). Similarly, wheezing was more
often audible in children infected with RSV (59%) than in
children with HMPV (47%) or RSV/HMPV co-infections
(25%), although this finding did not reach statistical signif-
icance (chi square for trend, p = 0.07). Eighteen (16%)
children had severe hypoxia with pO2 <90%, and 44 (40%)
had pO2 <94%. The presence of the viruses was associated
with the degree of hypoxia. Five (26%) of the 19 children
with HMPV had pO2 <94% compared to 25 (47%) of the
53 with RSV and 5 (63%) of the 8 with RSV/HMPV co-
infection (chi square for trend, p = 0.05). Severe hypoxia
(pO2 <90%), however, was less frequent in children with
HMPV (1 [5%] of 19) or RSV/HMPV co-infections (1
[13%] of 8) than in children with RSV infection (14 [26%]
of 53 (chi square for trend, p = 0.04). The lower prevalence
of hypoxia suggests that children with HMPV had milder
illnesses, since only 5 (26%) of the 19 HMPV patients and
2 (25%) of the 8 patients with RSV/HMPV co-infections
were admitted to hospital compared with 27 (51%) of the
53 with RSV infection, although this finding was not sta-
tistically significant. 
Conclusions 
This study is the first to describe HMPV in Latin
America. To date, information on the clinical signs and
symptoms and epidemiology of HMPV infection is limited.
Our study indicates that HMPV and RSV may have similar
signs and symptoms and can present as a co-infection. 
The incidence of HMPV increased at the same time that
the number of cases with RSV was increasing. HMPV,
however, was more prevalent in children attending periph-
eral clinics than the referral hospital. Similarly, children
with HMPV were less likely to be hypoxic and had lower
respiratory rates than those with RSV, which suggests that
HMPV infection may result in milder clinical signs and
symptoms. Further studies, however, are necessary to
explore if coinfected children are more or less likely to
have a worse clinical outcome than children infected with
only one virus. A recent report of hospitalized children in
intensive care suggested that dual infections could be asso-
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Figure 1. Number of children with respiratory syncytial virus (RSV),
human metapneumovirus (HMPV), and RSV/HMPV co-infection
by study week (week 10 incomplete).
Table. Characteristics of children with human metapneumovirus (HMPV), respiratory syncytial virus (RSV), and RSV/HMPV co-
infections
a 
  HMPV  RSV  RSV/HMPV co-infection  HMPV/RSV negative 
Characteristics  n = 19  n = 53  n = 8  n = 31 
Age in mo, mean (SD)  10.1 (5.4)  8.9 (7.2)  8.2 (6.0)  9.8 (7.7) 
Recruitment site
b          
Health center  12 (21)  23 (40.3)  6 (10.5)  16 (28.1) 
Private hospital  6 (20.7)  13 (44.8)  2 (6.9)  8 (27.6) 
Public hospital  1 (4)  17 (68)  0 (0)  7 (28) 
Male:female (% male)  12:7 (63)  36:17 (68)  4:4 (50)  21:10 (68) 
Birthweight <2,500 g  4 (21)  2 (4)  0 (0)  2 (6.5) 
Previous admission  2 (10)  7 (13)  3 (38)  1 (3) 
History of allergies  2 (11)  6 (11)  1 (13)  4 (13) 
Clinical signs and symptoms          
Respiratory rate, mean (SD)   44 (10.1)  51 (12.3)
c  54 (16.2)  46 (10.1) 
Temperature >37.5°C  15 (79)  43 (81)  8 (100)  23 (74) 
Runny nose  18 (95)  45 (85)  6 (75)  26 (84) 
Cyanosis  0 (0)  4 (7.5)  0 (0)  2 (6.5) 
Cough  19 (100)  53 (100)  8 (100)  31 (100) 
Wheezing  9 (47.4)  31 (58.5)  2 (25%)  19 (61.3) 
Chest indrawings  4 (21)  19 (36)  3 (37.5)  8 (25.8) 
pO2 <90%  1 (5.3)  10 (18.9)  0 (0)  1 (3.2) 
pO2 <94%
c  5 (26.3)  25 (47.2)  5 (62.5)  9 (29) 
aFigures are frequencies (%), unless otherwise specified.  
bHealth centers vs. public hospital, p < 0.01. Percentages are row percentages. 
cp < 0.05. ciated with increased severity (5). An alternative explana-
tion to reconcile these findings is the possibility that differ-
ent HMPV subgroups (2,9,10,13,16) produce clinical syn-
dromes of varying severity. 
Caution is necessary to interpret our findings as this
was a cross-sectional study. Virus in nasopharyngeal secre-
tions does not prove that it is the cause of the respiratory
symptoms, as we did not investigate the prevalence of the
virus in asymptomatic children or the natural history of the
infection. HMPV, however, has been associated with com-
munity-acquired respiratory illnesses (2,6,9–12) and
severe ALRI in immunocompromised patients (17,18), and
the virus was likely responsible for the clinical illness in
our children. Several studies have also described an asso-
ciation between HMPV and acute wheezing (3–5,8).
Although wheezing was a feature in 47% of the HMPV-
infected children, a greater proportion (59%) of children
infected with RSV had wheezing. The association between
RSV infection and asthma is well studied. However, most
children are exposed to RSV infections before the age of 2
years, and a combination of factors is likely required (19).
The coincidental timing of RSV and HMPV might have
led us to miss the true cause. The role of HMPV in ALRI
and asthma merits further investigation. Future studies
should aim to establish the natural history and clinical out-
come of these infections.
Dr. Cuevas is a senior lecturer in epidemiology at the
Liverpool School of Tropical Medicine. His main research inter-
est is investigating the epidemiology of meningitis, tuberculosis,
acute respiratory infections, and diarrhea.
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Figure 2. Number of children with respiratory syncytial virus (RSV),
human metapneumovirus (HMPV), and RSV/HMPV co-infection
by age.